303 related articles for article (PubMed ID: 6373932)
21. [Monoclonal antibodies against defined Leishmania antigens protect mice against infection by different species of Leishmania].
Monjour L; Berneman A; Vouldoukis I; Domurado M; Guillemin MC; Chopin C; Alfred C; Roseto A
C R Acad Sci III; 1985; 300(9):395-8. PubMed ID: 3922585
[TBL] [Abstract][Full Text] [Related]
22. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera.
Reed SG; Badaro R; Lloyd RM
J Immunol; 1987 Mar; 138(5):1596-601. PubMed ID: 3543131
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of antibody responses in Indian kala-azar by immunoblot.
Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP
Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503
[TBL] [Abstract][Full Text] [Related]
24. Epitope mapping of a common 57 kDa antigen of Leishmania species by monoclonal antibodies.
Nejad-Moghaddam A; Abolhassani M
Vaccine; 2010 Aug; 28(37):6036-40. PubMed ID: 20615488
[TBL] [Abstract][Full Text] [Related]
25. Immunostaining of visceral leishmaniasis caused by Leishmania infantum using monoclonal antibody (19-11) to the Leishmania homologue of receptors for activated C-kinase.
Hofman V; Brousset P; Mougneau E; Marty P; Lamant L; Antoine JC; Glaichenhaus N; Hofman P
Am J Clin Pathol; 2003 Oct; 120(4):567-74. PubMed ID: 14560568
[TBL] [Abstract][Full Text] [Related]
26. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
[TBL] [Abstract][Full Text] [Related]
27. [Immunoblotting in the study of the antigenic structure of Leishmania].
Goncharov DB; Kopacek P; Giboda M; Ditrich O; Saf'ianova VM
Med Parazitol (Mosk); 1990; (6):3-6. PubMed ID: 2290397
[TBL] [Abstract][Full Text] [Related]
28. Production and characterization of monoclonal antibodies to Leishmania donovani.
el-Amin el-Roufaie M; Kolk AJ; Wright EP; Pondman KW; Laarman JJ
Acta Leiden; 1985; 53():1-10. PubMed ID: 3836561
[No Abstract] [Full Text] [Related]
29. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with Leishmania donovani.
Bimal S; Bagchi AK; Das V; Sinha PK; Lal CS; Ranjan A; Gupta AK; Kar SK
Indian J Exp Biol; 2001 Sep; 39(9):878-82. PubMed ID: 11831368
[TBL] [Abstract][Full Text] [Related]
30. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
[TBL] [Abstract][Full Text] [Related]
31. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
[TBL] [Abstract][Full Text] [Related]
32. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
Tonui WK; Titus RG
Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
[TBL] [Abstract][Full Text] [Related]
33. Production and characterization of monoclonal antibodies recognizing a common 57-kDa antigen of Leishmania species.
Nejad-Moghaddam A; Abolhassani M
Iran Biomed J; 2009 Oct; 13(4):245-51. PubMed ID: 19946351
[TBL] [Abstract][Full Text] [Related]
34. In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major.
Zhang WW; Matlashewski G
Mol Microbiol; 2004 Nov; 54(4):1051-62. PubMed ID: 15522086
[TBL] [Abstract][Full Text] [Related]
35. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
[TBL] [Abstract][Full Text] [Related]
36. Antibody-induced modulation of Leishmania donovani surface membrane antigens.
Dwyer DM
J Immunol; 1976 Dec; 117(6):2081-91. PubMed ID: 792338
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to Leishmania tropica major: specificities and antigen location.
de Ibarra AA; Howard JG; Snary D
Parasitology; 1982 Dec; 85 (Pt 3)():523-31. PubMed ID: 6184664
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of the vaccination of C57BL/6 mice against infection with different species of Leishmania].
Monjour L; Ogunkolade W; Pointet P; Vouldoukis I
C R Acad Sci III; 1985; 301(18):803-6. PubMed ID: 3936605
[TBL] [Abstract][Full Text] [Related]
39. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
[No Abstract] [Full Text] [Related]
40. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A
Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
